0      0

AM21-59: Does Your Massive Transfusion Protocol Require Massive Revision?

‐ Oct 19, 2021 9:00pm

Expiration Date: Dec 31, 2023

Credits: None available.

Massive transfusion protocols (MTPs) are activated in the setting of uncontrolled hemorrhage. This session will help the audience identify potential unintended adverse medical and operational consequences of MTPs. It will begin with an engaging clinical case presentation and debrief. The 1st speaker will examine potential medical risk including: 1) misappropriate activation 2) immunohematologic complications 3) risk of transfusion-associated circulatory overload and 4) product appropriateness. The 2nd speaker will address ways to monitor and audit MTPs to find opportunities for institution-wide, patient-focused process improvement. Discussion will include: 1) what quality metrics should be captured and reviewed and 2) what is an effective quality management program that addresses communication and engages stakeholders outside of the laboratory. Last, we explore whether triggering one protocol for all patients is appropriate given the various clinical settings that require MTPs.

To view Spanish or English subtitles, click the "CC" box in the video player.
Para ver subtítulos en español o inglés, haga clic en el cuadro "CC" en el reproductor de video.

Learning Objectives:

  • Describe processes that create a rigorous quality management system to support safety and sustainability of effective massive transfusion protocols and debrief massive transfusion events
  • Explain the importance of intradepartmental and interdepartmental coordination and communication in safe and effective massive resuscitation
  • Debate the extent to which massive transfusion protocols could better reflect the ideals of “personalized medicine”
  • Recognize potential medical risks associated with massive transfusion protocols




  • Wen Lu, MD:
    Nothing to Disclose
  • Patricia Brunker, MD, DPhil(Oxon):
    Nothing to Disclose
  • J. Wade Atkins, MS, MT(ASCP) SBB, CQA (ASQ):
    Nothing to Disclose

All relevant financial relationships have been mitigated. By completing the evaluation, you are attesting to watching the presentation in its entirety. A certificate will be immediately provided after submission.

Credits Available

AM21-59: Does Your Massive Transfusion Protocol Require Massive Revision? Evaluation